RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Price:
4.12
TRY
1.73%
Market Cap:
₺2.1B
Relative Value
The Relative Value of one
RTALB.E
stock under the Base Case scenario is
hidden
TRY.
Compared to the current market price of 4.12 TRY,
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RTALB.E Relative Value
HIDDEN
Multiples Across Competitors
RTALB.E Competitors Multiples
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Competitors
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TR |
|
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
|
2.1B TRY | 11.1 | 8.9 | -43.8 | -32.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
394.1B USD | 6.6 | 167.9 | 16.3 | 23.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.3B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188.3B USD | 6.5 | 23.2 | 15.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.5B USD | 10.2 | 32.5 | 23.9 | 24.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.8B USD | 5.7 | 18.1 | 15.4 | 17.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
89B AUD | 4 | 20.6 | 13.8 | 17.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.4B EUR | 14 | 33 | 56.2 | 57.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
